Edwards Lifesciences Corporation Accounts Receivable
Edwards Lifesciences Corporation (EW) had Accounts Receivable of $770.40 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets › Assets, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2026-08-04
- 2026-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $770.40M.
- 2026-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $775.70M.
- 2025-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $659.60M.
- 2025-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $693.30M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current | Accounts Receivable, after Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2026-06-30 | $770.40M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $775.70M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $659.60M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $693.30M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $697.00M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $669.20M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $609.10M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $716.00M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $778.30M 10-Q · filed 2024-07-31 | |
| 2024-03-31 | $817.60M 10-Q · filed 2024-04-29 | |
| 2023-12-31 | $771.50M 10-K · filed 2025-02-28 | $775.10M 10-K · filed 2024-02-12 |
| 2023-09-30 | $739.80M 10-Q · filed 2023-10-27 | |
| 2023-06-30 | $754.40M 10-Q · filed 2023-07-28 | |
| 2023-03-31 | $717.70M 10-Q · filed 2023-04-28 | |
| 2022-12-31 | $643.00M 10-K · filed 2024-02-12 | |
| 2022-09-30 | $618.10M 10-Q · filed 2022-10-28 | |
| 2022-06-30 | $636.40M 10-Q · filed 2022-07-29 | |
| 2022-03-31 | $636.30M 10-Q · filed 2022-04-28 | |
| 2021-12-31 | $582.20M 10-K · filed 2023-02-13 | |
| 2021-09-30 | $600.60M 10-Q · filed 2021-10-29 | |
| 2021-06-30 | $640.50M 10-Q · filed 2021-07-30 | |
| 2021-03-31 | $586.60M 10-Q · filed 2021-04-28 | |
| 2020-12-31 | $514.60M 10-K · filed 2022-02-14 | |
| 2020-09-30 | $549.70M 10-Q · filed 2020-10-26 | |
| 2019-12-31 | $543.60M 10-K · filed 2021-02-12 | |
| 2018-12-31 | $456.90M 10-K · filed 2020-02-14 | |
| 2018-09-30 | $423.80M 10-Q · filed 2018-10-26 | |
| 2018-06-30 | $431.40M 10-Q · filed 2018-07-27 | |
| 2018-03-31 | $406.60M 10-Q · filed 2018-04-27 | |
| 2017-12-31 | $438.70M 10-K · filed 2019-02-15 | $421.60M 10-K · filed 2018-02-16 |
| 2016-12-31 | $365.50M 10-K · filed 2018-02-16 | |
| 2015-12-31 | $315.40M 10-K · filed 2017-02-17 | |
| 2014-12-31 | $288.00M 10-K · filed 2016-02-19 | |
| 2013-12-31 | $302.50M 10-K · filed 2015-02-20 | |
| 2012-12-31 | $321.10M 10-K · filed 2014-02-28 | |
| 2011-12-31 | $283.80M 10-K · filed 2013-02-28 | |
| 2010-12-31 | $277.30M 10-K · filed 2012-02-27 | |
| 2009-12-31 | $249.40M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |